Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

UFS professor receives international recognition for exceptional ethical values
2015-10-02

“You grow so fond of them,” Prof André Venter,
Head: Department of Paediatrics and Child Health,
says while doing his rounds with patients.
Prof Venter recently received the award for health professions
from the international organisation, Unashamedly Ethical.

“You are such a pretty baby,” Prof André Venter, Head: Department of Paediatrics and Child Health at the University of the Free State, whispers to a baby lying stretched out in her neonatal cradle.

He uses his fingertips to free her legs and arms carefully from the monitors and wires attached to her.

“See how much you have grown,” he says, tapping with his finger on her file. 1.2 kg - her weight indicates. 

In one of the other children’s wards, he joins a mother sitting with her sick baby. Speaking about the baby’s operation coming up within the next few months, he gives her an encouraging pat on the shoulder.

He visits yet another mother who is practising kangaroo care on her baby, and asks to hold the baby for a while.

“Gosh, you’re so nice and warm, let doctor hold you for a while,” he says, hugging the premature baby to his chest.

Prof Venter greets and thanks the nursing staff at the end of his ward rounds.

“Everything is not always good, but one can try to plan for the future from the challenges,” he says. “One should never concentrate on the immediate problem too much, but lift the morale of those using our services, those providing the services, and those who come here for training.”

It is this kind of passion and outlook that earned Prof Venter an ethical award from the international organisation, Unashamedly Ethical. The award, which was made in the health professions category, recognises doctors for exceptional ethical values and for going the extra mile in alleviating the suffering of humanity.

“I am humbled at being honoured for something I see as my passion and actually take for granted. I am also touched that people from outside noticed and nominated me for this,” he says.

He talks about his young patients again: “I learn so much from them each day. Children are so resistant to negative things. I grow so fond of them that I forget they have to go home some time.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept